Signaling pathway for TNF-α-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells

    loading  Checking for direct PDF access through Ovid

Abstract

We investigated the molecular mechanisms involved in the expression of matrix metalloproteinase-9 (MMP-9) and the inhibition of MMP expression by magnolol in 5637 human urinary bladder cancer cells. Tumor necrosis factor-α (TNF-α) stimulated the secretion of MMP-9 in 5637 cells, as shown by zymography and promoter assay. The transcription factor nuclear factor kappaB (NF-κB) binding site was identified by gel-shift assay to be a cis-element for TNF-α activation of the MMP-9 promoter. Our results also demonstrated that TNF-α stimulates MMP-9 expression via the p38 MAP kinase signaling pathway in 5637 cells. Moreover, p38 MAP kinase-mediated MMP-9 gene regulation in response to TNF-α is involved in the NF-κB response element in 5637 cells. In addition, magnolol inhibited TNF-α-induced expression of the MMP-9, as determined by zymography and immunoblot, in 5637 cells. The TNF-α-induced invasion and migration of cells was inhibited by magnolol, as assessed by a modified boyden chamber and wound-healing assays, respectively. Finally, magnolol blocked MMP-9 expression, at least in part, by decreasing the binding of transcription factor NF-κB to DNA. In conclusion, TNF-α induced MMP-9 expression in 5637 cells by activating the transcription factor NF-κB, which is involved in the p38 MAP kinase-mediated control of MMP-9 regulation. Magnolol inhibited MMP-9 expression through the transcription factor NF-κB in TNF-α-induced 5637 cells.

Related Topics

    loading  Loading Related Articles